Artificial Intelligence (AI) in Precision Medicine Market Report 2026

Artificial Intelligence (AI) in Precision Medicine Market Overview

• Artificial Intelligence (AI) in Precision Medicine market size has reached to $2.98 billion in 2025 • Expected to grow to $12.02 billion in 2030 at a compound annual growth rate (CAGR) of 32.2% • Growth Driver: Rising Prevalence Of Chronic Illnesses And Respiratory Disorders Drives The Artificial Intelligence In The Precision Medicine Market • Market Trend: Novel Ai-Based Life Sciences Solutions In Precision Medicine Market • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI) in Precision Medicine Market?

Artificial intelligence in precision medicine refers to leveraging sophisticated computation and inference to generate insights, enabling the system to reason and learn and helping healthcare professionals make decisions through augmented intelligence. Artificial intelligence in precision medicine is used to optimize diagnosis, therapeutic intervention, and prognosis in healthcare. The main components of artificial intelligence (AI) in precision medicine are hardware, software, and services. Hardware represents the actual components of a system or the ways it can store and execute the written instructions included in the application's software. The various technologies include deep learning, querying methods, natural language processing, and context-aware processing used in various therapeutic applications, including oncology, cardiology, neurology, respiratory, and others.

What Is The Artificial Intelligence (AI) in Precision Medicine Market Growth Forecast?

The artificial intelligence (AI) in precision medicine market size is expected to see exponential growth in the next few years. It will grow to $12.02 billion in 2030 at a compound annual growth rate (CAGR) of 32.2%. The growth in the forecast period can be attributed to integration of AI with genomics research, growth of personalized medicine adoption, increasing investment in precision healthcare, rising use of real world evidence, advancements in clinical AI platforms. Major trends in the forecast period include AI driven genomic data analysis, personalized treatment recommendation systems, predictive disease risk modeling, clinical decision support automation, real time patient data integration.

Global Artificial Intelligence (AI) in Precision Medicine Market Segmentation

1) By Component: Hardware, Software, Service 2) By Technology: Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing 3) By Therapeutic Application: Oncology, Cardiology, Neurology, Respiratory, Other Therapeutic Applications Subsegments: 1) By Hardware: AI Processors, High-Performance Computing Systems, Diagnostic Devices 2) By Software: AI Algorithms And Models, Data Analytics Platforms, Genomic Analysis Software, Clinical Decision Support Systems 3) By Service: Consulting Services, Integration Services, Maintenance And Support Services, Training And Education Services

What Is The Driver Of The Artificial Intelligence (AI) in Precision Medicine Market?

The high prevalence of chronic illnesses and respiratory disorders is expected to propel the growth of artificial intelligence in the precision medicine market going forward. Chronic illnesses refer to a medical condition that lasts longer than a year and requires ongoing medical attention, while respiratory disorders are diseases that affect the airways and the lungs. Artificial intelligence in precision medicine helps in diagnosing and predicting the outcomes for people suffering from respiratory diseases based on clinical data and chest imaging. It is used in precision medicine to treat chronic illnesses because it reduces costs and optimises resource utilisation. For instance, in May 2023, the United Nations, a US-based intergovernmental organisation, estimated that chronic diseases such as cardiovascular diseases, cancer, diabetes, and respiratory illnesses would account for 86% of the 90 million deaths by 2050. Additionally, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the death rate associated with chronic conditions increased by 490 deaths per 100,000 people in 2022. Therefore, the high prevalence of chronic illnesses and respiratory diseases will drive artificial intelligence in the precision medicine market.

Key Players In The Global Artificial Intelligence (AI) in Precision Medicine Market

Major companies operating in the artificial intelligence (AI) in precision medicine market are Alphabet Inc.; Microsoft Corporation; Intel Corporation; International Business Machines Corporation; AstraZeneca PLC; Sanofi S.A.; NVIDIA Corporation; GE HealthCare Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Helix Inc.; Sema4 Holdings Corp.; SOPHiA GENETICS SA; Insilico Medicine; BenevolentAI Limited; Fabric Genomics Inc.; Tempus Technologies Inc.; Enlitic Inc.; PathAI Inc.; Genuity Science Inc.; BERG LLC; Perthera Inc.; Vuno Inc.; CureMetrix Inc.; Zephyr AI; Freenome Inc.; PetaGene Ltd.; BioXcel Therapeutics Inc.

Global Artificial Intelligence (AI) in Precision Medicine Market Trends and Insights

Major companies operating in the artificial intelligence (AI) in precision medicine market are focusing on developing advanced such as artificial intelligence (AI)-based life sciences solutions such as protein structure prediction suites, to accelerate drug discovery, enhance target identification, and improve the efficiency of personalised treatment development. Protein structure prediction suites are artificial intelligence (AI)-driven tools that accurately model the three-dimensional structures of proteins to accelerate drug discovery and improve understanding of biological functions. For instance, in May 2023, Google LLC, a US-based technology corporation, introduced an AI-based life sciences solution called the Target and Lead Identification Suite, designed to accelerate in silico drug development. This suite helps research teams predict protein structures and accurately determine amino acid functions, thereby boosting the efficiency and precision of drug discovery and development in the field of precision medicine.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI) in Precision Medicine Market?

In July 2023, BioNTech SE, a Germany-based biotechnology company, acquired InstaDeep Ltd. for approximately £362 million. Through this acquisition, BioNTech aims to strengthen its AI-driven drug discovery and development capabilities by integrating InstaDeep’s advanced artificial intelligence and machine learning technologies. InstaDeep Ltd. is a UK-based technology company that provides AI-powered decision-making and machine learning solutions for drug discovery and development.

Regional Insights

North America was the largest region in the artificial intelligence (AI) in the precision medicine market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Intelligence (AI) in Precision Medicine Market?

The artificial intelligence in the precision medicine market consists of revenues earned by entities providing artificial intelligence in precision medicine services that include personalised treatment, disease prevention, and personalized diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. Artificial intelligence in the precision medicine market also includes sales of wearable devices, implantable devices, and artificial intelligence devices in precision medicine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI) in Precision Medicine Market Report 2026?

The artificial intelligence (ai) in precision medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) in precision medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.